Cutter & Co Brokerage’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,744
| Closed | -$1.62M | – | 3 |
|
|
2025
Q1 | $1.62M | Buy |
7,744
+672
| +10% | +$131K | 0.38% | 52 |
|
|
2024
Q4 | $1.26M | Sell |
7,072
-234
| -3% | -$43K | 0.31% | 58 |
|
|
2024
Q3 | $1.44M | Sell |
7,306
-89
| -1% | -$16.6K | 0.33% | 59 |
|
|
2024
Q2 | $1.27M | Buy |
7,395
+90
| +1% | +$14.9K | 0.31% | 59 |
|
|
2024
Q1 | $1.33M | Sell |
7,305
-352
| -5% | -$60.7K | 0.33% | 58 |
|
|
2023
Q4 | $1.19M | Buy |
7,657
+124
| +2% | +$18.1K | 0.33% | 59 |
|
|
2023
Q3 | $1.12M | Sell |
7,533
-127
| -2% | -$18.6K | 0.33% | 57 |
|
|
2023
Q2 | $1.03M | Buy |
7,660
+196
| +3% | +$28.7K | 0.3% | 60 |
|
|
2023
Q1 | $1.19M | Sell |
7,464
-466
| -6% | -$71.2K | 0.37% | 59 |
|
|
2022
Q4 | $1.28M | Sell |
7,930
-770
| -9% | -$118K | 0.43% | 53 |
|
|
2022
Q3 | $1.17M | Sell |
8,700
-558
| -6% | -$80.1K | 0.43% | 54 |
|
|
2022
Q2 | $1.42M | Sell |
9,258
-2,343
| -20% | -$358K | 0.48% | 52 |
|
|
2022
Q1 | $1.88M | Buy |
11,601
+1,913
| +20% | +$278K | 0.56% | 47 |
|
|
2021
Q4 | $1.31M | Buy |
9,688
+662
| +7% | +$78.2K | 0.36% | 68 |
|
|
2021
Q3 | $974K | Sell |
9,026
-265
| -3% | -$30.3K | 0.23% | 99 |
|
|
2021
Q2 | $1.05M | Buy |
9,291
+822
| +10% | +$92.6K | 0.24% | 95 |
|
|
2021
Q1 | $916K | Buy |
8,469
+1,603
| +23% | +$171K | 0.22% | 97 |
|
|
2020
Q4 | $736K | Buy |
6,866
+41
| +0.6% | +$3.94K | 0.19% | 111 |
|
|
2020
Q3 | $598K | Buy |
6,825
+2,363
| +53% | +$222K | 0.18% | 115 |
|
|
2020
Q2 | $438K | Buy |
4,462
+824
| +23% | +$72.5K | 0.14% | 127 |
|
|
2020
Q1 | $277K | Sell |
3,638
-306
| -8% | -$26.1K | 0.1% | 154 |
|
|
2019
Q4 | $349K | Buy |
3,944
+148
| +4% | +$12.3K | 0.12% | 151 |
|
|
2019
Q3 | $287K | Buy |
3,796
+973
| +34% | +$66.7K | 0.09% | 209 |
|
|
2019
Q2 | $205K | Sell |
2,823
-45
| -2% | -$3.54K | 0.06% | 263 |
|
|
2019
Q1 | $231K | Hold |
2,868
| – | – | 0.07% | 240 |
|
|
2018
Q4 | $264K | Buy |
2,868
+52
| +2% | +$4.57K | 0.1% | 195 |
|
|
2018
Q3 | $266K | Buy |
2,816
+176
| +7% | +$16.7K | 0.09% | 202 |
|
|
2018
Q2 | $245K | Buy |
2,640
+1
| +0% | +$98 | 0.09% | 197 |
|
|
2018
Q1 | $250K | Buy |
2,639
+86
| +3% | +$9.45K | 0.1% | 193 |
|
|
2017
Q4 | $247K | Buy |
+2,553
| New | +$241K | 0.1% | 187 |
|
|
2013
Q3 | – | Sell |
-5,835
| Closed | -$241K | – | 223 |
|
|
2013
Q2 | $241K | Buy |
+5,835
| New | +$255K | 0.11% | 168 |
|
Other funds holding ABBV
Cutter & Co Brokerage's ABBV Position: Q2 2025 in Review
Cutter & Co Brokerage sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 7,744 shares — an estimated $1.62M sold.
Cutter & Co Brokerage first reported a position in ABBV in Q2 2013 and held it in 31 quarters. The position peaked at $1.88M in Q1 2022. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.
- Cutter & Co Brokerage reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
- Cutter & Co Brokerage sold 7,744 AbbVie shares in Q2 2025, an estimated $1.62M.
- Cutter & Co Brokerage first reported a position in AbbVie in Q2 2013 and held it in 31 quarters.
- Cutter & Co Brokerage's AbbVie position peaked at $1.88M in Q1 2022.
- 3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.
Based on Cutter & Co Brokerage's 13F filing for Q2 2025.